Comparative efficiency of pathogen treatment of acute respiratory viral infections
The article presents the results of clinical studies on the comparative effectiveness of different forms of the drug Cytovir-3 (syrup and powder for solution for oral administration) and Immunal l in the treatment of acute respiratory viral infections in children. It was found in a comparative rando...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Central Research Institute for Epidemiology
2016-12-01
|
| Series: | Вопросы вирусологии |
| Subjects: | |
| Online Access: | https://virusjour.crie.ru/jour/article/viewFile/105/36 |
| _version_ | 1797782222493712384 |
|---|---|
| author | S. V. Petlenko L. V. Osidak V. S. Smirnov N. I. Stukan’ O. I. Afanas’Eva E. G. Golovacheva |
| author_facet | S. V. Petlenko L. V. Osidak V. S. Smirnov N. I. Stukan’ O. I. Afanas’Eva E. G. Golovacheva |
| author_sort | S. V. Petlenko |
| collection | DOAJ |
| description | The article presents the results of clinical studies on the comparative effectiveness of different forms of the drug Cytovir-3 (syrup and powder for solution for oral administration) and Immunal l in the treatment of acute respiratory viral infections in children. It was found in a comparative randomized parallel-group study of 90 children aged two through six years that the drug Cytovir-3 (syrup and powder) became active faster than the comparison drug Immunal, providing normalization of body temperature, reduction of some manifestations of the general intoxication and respiratory syndrome, as well as elevated levels of serum immunoglobulin A. All drugs in the study had an equally normalizing effect on the content of peripheral blood leukocytes and erythrocyte sedimentation rates. The compared products were characterized by good tolerability, lack of side effects and high preventive efficacy against respiratory disease complications. Cytovir-3 drugs (syrup and powder for oral solution) and Immunal had similar ratios of clinical and laboratory safety, efficacy and tolerability. Both products can be used for the treatment of respiratory diseases in children aged two through six years. |
| first_indexed | 2024-03-13T00:07:57Z |
| format | Article |
| id | doaj.art-a089b8ba65044799b5ebf0bd2745a7a5 |
| institution | Directory Open Access Journal |
| issn | 0507-4088 2411-2097 |
| language | English |
| last_indexed | 2024-03-13T00:07:57Z |
| publishDate | 2016-12-01 |
| publisher | Central Research Institute for Epidemiology |
| record_format | Article |
| series | Вопросы вирусологии |
| spelling | doaj.art-a089b8ba65044799b5ebf0bd2745a7a52023-07-12T20:03:23ZengCentral Research Institute for EpidemiologyВопросы вирусологии0507-40882411-20972016-12-0161626326910.18821/0507-4088-2016-61-6-263-26986Comparative efficiency of pathogen treatment of acute respiratory viral infectionsS. V. Petlenko0L. V. Osidak1V. S. Smirnov2N. I. Stukan’3O. I. Afanas’Eva4E. G. Golovacheva5Biomedical Research and Production Complex “Cytomed”Research Institute of InfluenzaBiomedical Research and Production Complex “Cytomed”Biomedical Research and Production Complex “Cytomed”Research Institute of InfluenzaResearch Institute of InfluenzaThe article presents the results of clinical studies on the comparative effectiveness of different forms of the drug Cytovir-3 (syrup and powder for solution for oral administration) and Immunal l in the treatment of acute respiratory viral infections in children. It was found in a comparative randomized parallel-group study of 90 children aged two through six years that the drug Cytovir-3 (syrup and powder) became active faster than the comparison drug Immunal, providing normalization of body temperature, reduction of some manifestations of the general intoxication and respiratory syndrome, as well as elevated levels of serum immunoglobulin A. All drugs in the study had an equally normalizing effect on the content of peripheral blood leukocytes and erythrocyte sedimentation rates. The compared products were characterized by good tolerability, lack of side effects and high preventive efficacy against respiratory disease complications. Cytovir-3 drugs (syrup and powder for oral solution) and Immunal had similar ratios of clinical and laboratory safety, efficacy and tolerability. Both products can be used for the treatment of respiratory diseases in children aged two through six years.https://virusjour.crie.ru/jour/article/viewFile/105/36cytovir-3immunalrandomized clinical trialchildrencomparative effectiveness |
| spellingShingle | S. V. Petlenko L. V. Osidak V. S. Smirnov N. I. Stukan’ O. I. Afanas’Eva E. G. Golovacheva Comparative efficiency of pathogen treatment of acute respiratory viral infections Вопросы вирусологии cytovir-3 immunal randomized clinical trial children comparative effectiveness |
| title | Comparative efficiency of pathogen treatment of acute respiratory viral infections |
| title_full | Comparative efficiency of pathogen treatment of acute respiratory viral infections |
| title_fullStr | Comparative efficiency of pathogen treatment of acute respiratory viral infections |
| title_full_unstemmed | Comparative efficiency of pathogen treatment of acute respiratory viral infections |
| title_short | Comparative efficiency of pathogen treatment of acute respiratory viral infections |
| title_sort | comparative efficiency of pathogen treatment of acute respiratory viral infections |
| topic | cytovir-3 immunal randomized clinical trial children comparative effectiveness |
| url | https://virusjour.crie.ru/jour/article/viewFile/105/36 |
| work_keys_str_mv | AT svpetlenko comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections AT lvosidak comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections AT vssmirnov comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections AT nistukan comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections AT oiafanaseva comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections AT eggolovacheva comparativeefficiencyofpathogentreatmentofacuterespiratoryviralinfections |